A detailed analysis of First pass Reperfusion and Number of Passes in MeVO Stroke Thrombectomy
BACKGROUND AND PURPOSE: Reperfusion success after EVT and the number of EVT passes may be associated with clinical and imaging outcomes in patients with acute stroke due to Medium Vessel Occlusion (MeVO). MATERIAL AND METHODS: Secondary analysis of patients randomized to EVT in the ESCAPE-MeVO trial. Final reperfusion was assessed with the MeVO-expanded Thrombolysis in Cerebral Infarction (MeVO-eTICI) Score. First pass near-complete reperfusion was defined as MeVO-eTICI 2c-3 after 1 pass and multi-pass near-complete reperfusion as MeVO-eTICI 2c-3 after >1 pass. The primary outcome was the modified Rankin Score (mRS) at 90 days. Secondary outcomes included 24-hour NIHSS and 24-hour infarct volume, among others. Associations were assessed using regression models. RESULTS: Of 255 patients randomized to EVT (48.3%), 206 remained for the final analysis. First pass near-complete reperfusion was associated with decreased infarct volume (median 12.8ml [IQR 0.15-25.3] versus: 22.4ml [6.71-56.38ml], adjusted beta-coefficient -1.68 [95%CI::-2.54-(-0.81)]) and improved 24-hour NIHSS (median 7 [2-13.5] versus: 2.5 [1-6.5], adjusted beta-coefficient -0.56 [95%CI:-0.74-(-0.38)]), but not with clinical outcomes. Similarly, improved reperfusion status was associated with lower infarct volumes and improved 24-hour NIHSS but not with clinical outcomes. Number of EVT passes was associated with higher 90-day mRS (acOR 1.41 [95%CI: 1.04-1.91] per 1-additional pass), higher 24-hour NIHSS and larger infarct volume. CONCLUSIONS: Improved first-pass reperfusion with EVT in MeVO stroke patients was associated with reduced infarct volumes and improved 24-hour NIHSS. Performing more EVT passes was associated with increased infarct volume and poorer 24-hour and 90-day outcomes.
Authors
- Shahid Mehdi Nimjee (ORCID: https://orcid.org/0000-0002-0317-8731)
- David Volders (ORCID: https://orcid.org/0000-0003-4074-8702)
- Johanna Ospel
- William K. Diprose (ORCID: https://orcid.org/0000-0002-3808-4428)
- Alexander Stebner (ORCID: https://orcid.org/0009-0003-8895-0894)
- Mouhammad A. Jumaa (ORCID: https://orcid.org/0000-0002-7165-797X)
- Kazutaka Uchida (ORCID: https://orcid.org/0000-0003-4780-9598)
- Mayank Goyal (ORCID: https://orcid.org/0000-0001-9060-2109)
- Salome Lou Bosshart (ORCID: https://orcid.org/0009-0007-7570-8723)
- Markus Möhlenbruch
- Thomas Booth
- Brian Buck
- Michael D Hill
- Dar Dowlatshahi
- James Kennedy
- on behalf of the ESCAPE-MeVO investigators
Institutions
- University Health Network (CA)
- University of Ottawa (CA)
- University of Auckland (NZ)
- University of Alberta (CA)
- University of Calgary (CA)
- University of Basel (CH)
- Heidelberg University (DE)
- Toronto Western Hospital (CA)
- University Hospital Heidelberg (DE)
- Foothills Medical Centre (CA)
- University Hospital of Basel (CH)
- The Ohio State University (US)
Publication Details
- Journal
- American Journal of Neuroradiology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3174/ajnr.a9715
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00